Champions Oncology, Inc. is a biotechnology research services company focused on oncology drug development. Champions Oncology provides preclinical and clinical specialty testing, translational research, and data-driven software solutions that help pharmaceutical and biotechnology companies evaluate cancer therapies. Its core offerings include proprietary tumor models, in vivo and ex vivo research platforms, biomarker analysis, and the TumorGraft technology platform, which supports more personalized approaches to oncology research. The company also offers Lumin Bioinformatics, a software platform that combines research and clinical data for computational cancer analysis and decision-making support. Champions Oncology serves drug developers, research organizations, and medical professionals through technology-enabled services centered on improving the understanding and development of cancer treatments. Headquartered in Hackensack, New Jersey, Champions Oncology operates as a specialized provider within the broader oncology contract research and life sciences tools market.
WebsiteOne University Plaza
Hackensack, NJ, 07601
United States
Champions Oncology Inc (CSBR) posted 9% revenue growth, 50% gross margin, and record data licensing revenue in Q1 fiscal 2027.
Motley Fool Press Release.
Moby summary of Champions Oncology, Inc.'s Q1 2027 earnings call
Champions Oncology (NASDAQ:CSBR) reported first-quarter fiscal 2027 revenue growth, improved margins and its fifth consecutive quarter of positive adjusted EBITDA, as both its translational oncology services and data licensing businesses contributed to results. Revenue for the quarter totaled $15.2
Investors talking about CSBR also mention
What share of all stock conversation is about CSBR?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Attention | 0% 0 | 0% 0 | 0% 0 | 0% 0 |
Of the messages about CSBR that take a side, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Bullish | — | — | — | 56.52% -43.48 | ||
| Bearish | — | — | — | 43.48% +43.48 |
Of the messages about CSBR that carry a topic, what share is each?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Announcements | — | — | 100% | 71.74% | ||
| Earnings | — | — | 0% | 28.26% | ||
| Analysts | — | — | 0% | 0% | ||
| Controversies | — | — | 0% | 0% | ||
| Macro | — | — | 0% | 0% | ||
| Technical Analysis | — | — | 0% | 0% |
Of the messages about CSBR, what share comes from each group?
| 1 Day1D | 1 Week1W | 1 Month1M | 1 Year1Y | 50-Day MAclick to plot | 200-Day MAclick to plot | |
|---|---|---|---|---|---|---|
| Regulars | — | 0% | 21.05% | 16.39% | ||
| Newcomers | — | 100% | 78.95% | 83.61% |